Joslin and Brigham Compare Treatments for Obesity and Diabetes
Dr. Osama Hamdy, right
Thursday, February 25, 2010
Recent studies suggest that bariatric surgery (which promotes weight loss by restricting the body’s ability to take in and process nutrients) may lead to impressive resolutions or even cures for many with type 2 diabetes. During the past decade there also have been many advances with new medications and innovative programs for intensive medical diabetes and weight management programs. Joslin and Brigham and Women’s Hospital are joining forces for a clinical trial, now recruiting volunteers in greater Boston, which will compare these two types of treatment.
The project is led by Dr. David Lautz, Director of Bariatric Surgery at Brigham and Women's Hospital and Instructor at Harvard Medical School, and Dr. Allison Goldfine, Head of Clinical Research at Joslin and Associate Professor of Medicine at Harvard Medical School. The two physician researchers have teamed up to compare the effectiveness of two popular types of bariatric surgery to an intensive lifestyle modification and medical management program called Weight Achievement and Intensive Treatment (Why WAIT?) in obese patients with type 2 diabetes.
Known as SLIMM-T2D (Surgery or Lifestyle with Intensive Medical Management in the Treatment of Type 2 Diabetes), the two-year study will examine whether patients test in the non-diabetic range one year after either the surgical or medical and weight management interventions.
Joslin Research Updates
Page last updated: March 11, 2014